ERCAL, a regional initiative for rare diseases in Latin America and the Caribbean

Abstract

The importance of establishing programs to address the challenges of patients living with rare diseases has been recognized internationally, yet many countries, especially in low- and middle-income regions, are lagging in the recognition of the challenges and needs of patients and families. To improve this situation, the Enfermedades Raras en el Caribe y America Latina (ERCAL) initiative was established in 2020 with the vision of bringing together patients, patient representatives, organizations, researchers, clinicians, regulators, and all interested stakeholders in the rare diseases ecosystem under a common collaborative platform to sum efforts to improve the lives of patients and families living with rare diseases in the Latin American and the Caribbean region. Over the last three years, we have been working consistently to establish an agenda of priorities and objectives to guide the work of the initiative and address the major challenges faced by the rare disease community in the region.

Keywords

Rare diseases / Latin America / ERCAL / CEPCAL / collaboration / precision medicine

References

[1] Comisión Económica para América Latina y el Caribe (CEPAL). The world has 8 billion people, 662 million of whom live in Latin America and the Caribbean. Available from: https://www.cepal.org/en/news/world-has-8-billion-people-662-million-whom-live-latin-america-and-caribbean [Last accessed on 22 Feb 2024].

[2] Orphan Drug Act of 1983. US Food and Drug Administration. Public law 97-414 -Jan. 4, 1983. Available from: https://www.govinfo.gov/content/pkg/STATUTE-96/pdf/STATUTE-96-Pg2049.pdf [Last accessed on 22 Feb 2024].

[3] European Commission. Rare diseases. EU research on rare diseases. Available from: https://ec.europa.eu/info/research-and-innovation/research-area/health-research-and-innovation/rare-diseases_en [Last accessed on 22 Feb 2024].

[4] Gonzaga-Jauregui C.Genomics of rare diseases: understanding disease genetics using genomic approaches. A volume in translational and applied genomics. Amsterdam: Elsevier Inc.; 2021.

[5] Haendel M,Unni D.How many rare diseases are there?.Nat Rev Drug Discov2020;19:77-8 PMCID:PMC7771654

[6] Dias AG,Barrera Ortiz L.Rarecare: a policy perspective on the burden of rare diseases on caregivers in Latin America.Front Public Health2023;11:1127713 PMCID:PMC10017724

[7] Forman J,Llera VA.International Conference for Rare Diseases and Orphan Drugs (ICORD)The need for worldwide policy and action plans for rare diseases.Acta Paediatr2012;101:805-7 PMCID:PMC3443385

[8] Baynam GS,van der Westhuizen FH.A call for global action for rare diseases in Africa.Nat Genet2020;52:21-6

[9] 1er congreso de enfermedades raras de latinoamérica y el caribe - congresoERCAL. Available from: https://sites.google.com/view/cepcal/proyectos-projetos/congreso-cepcal/1er-congresoercal [Last accessed on 27 Feb 2024].

[10] United Nations. Resolution adopted by the general assembly on 16 December 2021. Addressing the challenges of persons living with a rare disease and their families. Available from: https://www.rarediseasesinternational.org/wp-content/uploads/2022/01/Final-UN-Text-UN-Resolution-on-Persons-Living-with-a-Rare-Disease-and-their-Families.pdf [Last accessed on 22 Feb 2024].

[11] World Health Organization. Accelerating access to genomics for global health: promotion, implementation, collaboration, and ethical, legal, and social issues: a report of the WHO Science Council. Available from: https://www.who.int/publications/i/item/9789240052857 [Last accessed on 22 Feb 2024].

[12] Giugliani R,Hafez S.Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America.Front Genet2022;13:1053559 PMCID:PMC9773081